Seqirus
is an England-based pharmaceutical company that supplies seasonal influenza vaccines for the healthcare industry... Read moreSeqirus
is an England-based pharmaceutical company that supplies seasonal influenza vaccines for the healthcare industry... Read more
News
Sep 28, 2023
Pharmabiz
Seqirus: UKHSA announces new UKbased vaccine deal to boost pandemic preparedness against influenza
Dec 13, 2022
Pharamceutical Technology
Seqirus: CSL closes mRNA vaccine deal with Arcturus
Nov 02, 2022
BioSpace
Seqirus: CSL Seqirus and Arcturus Ink $4.3 Billion mRNA Vaccine Deal
Oct 07, 2022
Endpoints News
Seqirus: CSL Seqirus snaps up $30M+ BARDA contract to develop influenza vaccine at its expanded facility in NC
Oct 06, 2022
Markets Insider
Seqirus: CSL Seqirus Announces U.S. Government Award to Manufacture and Clinically Assess Influenza A(H5N8) Pre-Pandemic Vaccine
Sep 26, 2022
Markets Insider
Seqirus: New Real-World Data Presented at OPTIONS XI Show Cell-Based and MF59-Adjuvanted Influenza Vaccines Can Reduce the Burden of Seasonal Influenza on Hospitals and Health Systems
Sep 26, 2022
Nasdaq
Seqirus: CSL Seqirus: New Study Suggests To Increase Vaccination Rate For Influenza To 70% Or Higher
Jul 11, 2022
Markets Insider
Seqirus: Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2022/23 U.S. Season
Jun 23, 2022
FinanzNachrichten
Seqirus: CDC Panel Recommends Older Adults Receive Enhanced Flu Vaccine, Incl. Fluad Quadrivalent
Jun 08, 2022
Endpoints News
Seqirus: CSL's Seqirus caps off $156M expansion of flu manufacturing facility in Raleigh suburb
Seqirus Competitors
1
2
3
4
5
6
7
8
9
10